Bengal Acquisition

Bengal Acquisition Corp. was a special purpose acquisition company (SPAC) specifically targeting the healthcare and life sciences industries. The company was formed to facilitate a merger, capital stock exchange, or similar business combination with a high-potential healthcare business. Its leadership team featured industry veterans, including CEO Josh Levine and Chairman Andrew Conrad, who brought significant experience from Verily and Accuray. The firm focused on identifying targets within the biotechnology, medical device, and healthcare technology sectors that could benefit from the public capital markets. Despite its efforts to secure a partner, the company was unable to finalize a business combination within the required regulatory period. In October 2023, the company announced it would redeem all outstanding shares and liquidate.